Life Expectancy Estimation with Breast Cancer: Bias of the Declining Exponential Function and an Alternative to Its Use

Abstract

Background. Life expectancy gain (LEG) is an outcome measure commonly estimated with a declining exponential function in a Markov model. The accuracy of such estimates has not been objectively evaluated. Purpose. To compare LEGs from declining exponential function estimates with those calculated from population data, using published screening mammography studies as examples. Method. SEER-based population data are used to compare LEG calculation with declining exponential function estimation and empinc population data in a new model, the "nested" Markov. Results. Analyses of the LEG of mammographic screening based on the declining exponential function significantly overestimate LEGs for younger women and underestimate them for older women. Because of offsetting errors, all-age analyses paradoxically appear accurate. Conclusion. Declining exponential function estimates of LEGs for chronic diseases with low mortality rates and long time horizons are liable to significant bias, especially with limited age cohorts. Key words: life expectancy; survival; mortality; DEALE; Markov model; misestimation bias; misspecification bias. (Med Decis Making 1999; 19:385-393)

Get full access to this article

View all access options for this article.

References

Lewis B. Breast cancer In: Wyngarden J , Smith L , Bennett J (eds) Cecil Textbook of Medicine, Philadelphia, PA: W. B. Saunders, 1992 1381-6

Henderson I. Breast cancer In Isselbacher K , Braunwald E , Wilson J (eds) Harrison's Principles of Internal Medicine New York McGraw-Hill, 1998.1840-50

Wright J. , Weinstein M.

Gains in life expectancy from medical interventions—standardizing data on outcomes

N Engl J Med. 1998,339 380-6

Detsky A. , Redelmeier D. Measuring health outcomes-putting gains into perspective [editorial] . N Engl J Med 1999, 339:402-3

Lee E. Some well-known survival distributions and their applications. In: Lee E (ed) Statistical Methods for Survival Data Analysis. New York- John Wiley & Sons 1992 131-4

Kuntz K. , Weinstein M.

Life expectancy biases in clinical decision modeling

Med Decis Making 1995;15:158-69

Beck J. , Kassirer J. , Pauker S. A convenient approximation of life expectancy (the DEALE) 1) Validation of the method, and 2) Use in medical decision making. Am J Med 1982;73:883-97.

Kattlove H. , Liberati A. , Keeler E. , Brook R.

Benefits and cost of screening and treatment for early breast cancer development of a basic benefit package

JAMA 1995;273-142-8

Beck J. , Pauker S.

The

Markov process in medical prognosis Med Decis Making 1983;3:419-28

10.

Sonnenberg F. , Beck J.

Markov models in medical decision making. a practical guide

Med Decis Making 1993;13 322-38.

11.

Lindfors K. , Rosenquist J. The cost-effectiveness of mammographic screening strategies. JAMA 1995,274:881-4

12.

Rosenquist C. , Lindfors K.

Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness

Cancer 1998,82:2235-40

13.

Rosenquist C. , Lindfors K.

Screening mammography in women aged 40-49 years analysis of cost-effectiveness

Radiology . 1994,191 647-50

14.

Lindfors K. , Rosenquist C. Needle core biopsy guided with mammography a study of cost-effectiveness. Radiology. 1994,190.217-22

15.

Hillner B. , Smith T.

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision analysis model

N Engl J Med 1991;324 160-8.

16.

Hillner B. , Smith T. , Desch C.

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer Estimates using decision analysis while awaiting clinical trials

JAMA. 1992,267 2055-61

17.

Verhoef C. , Stalpers L. , Verbeek A. , Wobbes T. , van Daal W. Breast-conserving treatment or mastectomy in early breast cancer a clinical decision analysis with special reference to the risk of local recurrence . Eur J Cancer 1991,27:1132-7

18.

Schrag D. , Kuntz K. , Garber J. , Weeks J. Decision analysis— effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCAL or BRCA2 mutations. N Engl J Med 1997,336.1465-71

19.

Benbassat J. , Zajicek G. , Van Ooortmarssen G. , Ben-dov I. , Eckman M.

Inaccuracies in estimates of life expectancies with bronchial cancer in clinical decision making

Med Decis Making 1993; 13 237-44.

20.

Djulbegovic B. An estimation of life expectancy: the method is a message. (commentary). Med Decis Making. 1993;13:245-6.

21.

Yakovlev A. , Tsodikov A. , Boucher K. , Kerber R. , Allison CJ

The shape of the hazard function in breast carcinoma: curability of the disease revisted

Cancer 1999,85 1789-98

22.

U S. Department of Health and Human Services SEER Cancer Incidence Public-Use Database, 1973-1995 Information Management Services, Inc , Silver Spring, MD 20904, 1999

23.

Chiang C. The life table and its construction—the complete life table In Chiang C (ed) The Life Table and Its Applications Malabar, FL. Robert E Krieger, 1984 113-36.

24.

Chiang C. Statistical inference regarding life table functions In The Life Table and Its Applications Malabar, FL, Robert E. Krieger, 1984-153-67

25.

SEER cancer statistics review, 1973-1995 Section 4-Breast (http//www.-seerims.ncinihgove/Publications/CSR7395/breastpdf) 1999

26.

GMWK291. Death rates from 72 selected causes by 5-year age groups, race, and sex United States, 1979-96 (http://www.cdcgov/nchswww./datawh/statab/unpubd/mortabshtm), 1999

27.

Salzmann P. , Kerlikowske K. , Phillips K.

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age

Ann Intern Med 1997,127 :955-65.